-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Today's biggest pre-market stock movers: 10 top gainers and losers on Tuesday
Today's biggest pre-market stock movers: 10 top gainers and losers on Tuesday
Gainers
$Communications Systems Inc(JCS.US)$ rose 34.8% to $9.15 in pre-market trading as the company declared a special dividend of $3.50 per share.
$DatChat(DATS.US)$ rose 16.2% to $7.60 in pre-market trading after gaining around 4% on Monday.
$Akerna Corp(KERN.US)$ rose 11.5% to $3.69 in pre-market trading. The company agreed to acquire 365 Cannabis, a cannabis business management software system built on Microsoft's Dynamics 365 Business Central in a $17 million deal.
$PainReform Ltd(PRFX.US)$ rose 10.8% to $3.11 in pre-market trading.
$Nanoviricides Inc(NNVC.US)$ rose 10.5% to $4.50 in pre-market trading after the company said it completed licensing for current drug development.
$aTyr Pharma Inc(LIFE.US)$ shares rose 10.3% to $10.09 in pre-market trading. aTyr Pharma shares jumped 67% on Monday after the company announced the Phase 1b/2a clinical trial of ATYR1923 in pulmonary sarcoidosis met its primary endpoint.
$NRX Pharmaceuticals(NRXP.US)$ rose 10% to $12.08 in pre-market trading after IQVIA announced a collaboration with the company on potential medical support for novel treatment.
$CYREN Ltd(CYRN.US)$ rose 9% to $0.6330 in pre-market trading. Cyren and Improving recently reported a partnership to 'strengthen phishing defense for Microsoft 365.'
$Oscar Health, Inc.(OSCR.US)$ rose 9% to $18.64 in pre-market trading. Oscar Health Co-Founder Joshua Kushner reported the purchase of 1,072,264 shares at an average price of $17.41 per share in Form 4 Filing.
$In8bio(INAB.US)$ rose 8.8% to $9.63 in pre-market trading. IN8BIO recently reported a net loss of $1.00 per share for the second quarter, versus a year-ago loss of $0.92 per share.
$Amryt Pharma PLC(AMYT.US)$ rose 7.7% to $11.50 in pre-market trading. Amryt boosted full year 2021 revenue guidance to $220 million - $225 million.
$Ur-Energy Inc(URG.US)$ rose 6.7% to $1.90 in pre-market trading after climbing over 7% on Monday.
$Eyegate Pharmaceuticals Inc(EYEG.US)$ rose 6% to $1.78 in pre-market trading. EyeGate Pharma recently completed target enrollment in Phase 2 proof-of-concept study to evaluate PP-001 for the treatment of ocular surface inflammation.
$Matinas BioPharma Holdings Inc(MTNB.US)$ rose 5.7% to $1.11 in pre-market trading. Matinas BioPharma shares climbed 27% on Monday after the company announced data in the ongoing EnACT trial of MAT2203 for treatment of Cryptococcal Meningitis.
$Markforged Holding Corp(MKFG.US)$ shares rose 5.5% to $8.06 in pre-market trading after dropping 5% on Monday.
Losers
$TMC THE METALS CO INC(TMC.US)$ shares fell 10.8% to $11.10 in pre-market trading after jumping 32% on Monday.
$Renalytix AI PLC(RNLX.US)$ shares fell 7.4% to $21.35 in pre-market trading.
$Old Republic International Corp(ORI.US)$ shares fell 5.5% to $23.73 in pre-market trading.
$Support.com(SPRT.US)$ shares fell 5% to $18.16 in pre-market trading after dropping 9% on Monday. The stock has been circulated as a potential short squeeze candidate on social media.
$Aluminum Corporation Of China(ACH.US)$ fell 5% to $22.09 in pre-market trading after gaining over 8% on Monday.
Gainers
赢家
$Communications Systems Inc(JCS.US)$ rose 34.8% to $9.15 in pre-market trading as the company declared a special dividend of $3.50 per share.
$DatChat(DATS.US)$ rose 16.2% to $7.60 in pre-market trading after gaining around 4% on Monday.
$Akerna Corp(KERN.US)$ rose 11.5% to $3.69 in pre-market trading. The company agreed to acquire 365 Cannabis, a cannabis business management software system built on Microsoft's Dynamics 365 Business Central in a $17 million deal.
$PainReform Ltd(PRFX.US)$ rose 10.8% to $3.11 in pre-market trading.
$Nanoviricides Inc(NNVC.US)$ rose 10.5% to $4.50 in pre-market trading after the company said it completed licensing for current drug development.
$aTyr Pharma Inc(LIFE.US)$ shares rose 10.3% to $10.09 in pre-market trading. aTyr Pharma shares jumped 67% on Monday after the company announced the Phase 1b/2a clinical trial of ATYR1923 in pulmonary sarcoidosis met its primary endpoint.
$NRX Pharmaceuticals(NRXP.US)$ rose 10% to $12.08 in pre-market trading after IQVIA announced a collaboration with the company on potential medical support for novel treatment.
$CYREN Ltd(CYRN.US)$ rose 9% to $0.6330 in pre-market trading. Cyren and Improving recently reported a partnership to 'strengthen phishing defense for Microsoft 365.'
$Oscar Health, Inc.(OSCR.US)$ rose 9% to $18.64 in pre-market trading. Oscar Health Co-Founder Joshua Kushner reported the purchase of 1,072,264 shares at an average price of $17.41 per share in Form 4 Filing.
$In8bio(INAB.US)$ rose 8.8% to $9.63 in pre-market trading. IN8BIO recently reported a net loss of $1.00 per share for the second quarter, versus a year-ago loss of $0.92 per share.
$Amryt Pharma PLC(AMYT.US)$ rose 7.7% to $11.50 in pre-market trading. Amryt boosted full year 2021 revenue guidance to $220 million - $225 million.
$Ur-Energy Inc(URG.US)$ rose 6.7% to $1.90 in pre-market trading after climbing over 7% on Monday.
$Eyegate Pharmaceuticals Inc(EYEG.US)$ rose 6% to $1.78 in pre-market trading. EyeGate Pharma recently completed target enrollment in Phase 2 proof-of-concept study to evaluate PP-001 for the treatment of ocular surface inflammation.
$Matinas BioPharma Holdings Inc(MTNB.US)$ rose 5.7% to $1.11 in pre-market trading. Matinas BioPharma shares climbed 27% on Monday after the company announced data in the ongoing EnACT trial of MAT2203 for treatment of Cryptococcal Meningitis.
$Markforged Holding Corp(MKFG.US)$ shares rose 5.5% to $8.06 in pre-market trading after dropping 5% on Monday.
$通信系统公司(JCS.US)$ 在盘前交易中，该公司股价上涨34.8%，至9.15美元，该公司宣布派发每股3.50美元的特别股息。
$DatChat(DATS.US)$在周一上涨约4%后，该股在盘前交易中上涨16.2%，至7.60美元。
$Akerna Corp(KERN.US)$在盘前交易中，该股上涨11.5%，至3.69美元。该公司同意以1700万美元的价格收购365大麻，这是一个基于微软Dynamics 365商业中心的大麻商业管理软件系统。
$PainChanging Ltd(PRFX.US)$在盘前交易中，该股上涨10.8%，至3.11美元。
$NanoViricdes Inc.(NNVC.US)$在盘前交易中，该公司上涨10.5%，至4.50美元，此前该公司表示，已完成当前药物开发的许可。
$aTyr Pharma Inc.(LIFE.US)$在盘前交易中，该公司股价上涨10.3%，至10.09美元。ATyr Pharma股价周一上涨67%，此前该公司宣布，ATYR1923治疗肺结节病的1b/2a期临床试验达到了主要终点。
$NRX制药公司(NRXP.US)$在IQVIA宣布与该公司就新疗法的潜在医疗支持进行合作后，该公司在盘前交易中上涨10%，至12.08美元。
$CYREN有限公司(CYRN.US)$在盘前交易中，该公司股价上涨9%，至0.6330美元。CyREN和Improving最近报道了一项合作伙伴关系，以加强对微软365的网络钓鱼防御。
$Oscar Health，Inc.(OSCR.US)$在盘前交易中，该股上涨9%，至18.64美元。Oscar Health联合创始人约书亚·库什纳在Form 4文件中报告称，该公司以每股17.41美元的平均价格购买了1,072,264股票。
$IN8BIO(INAB.US)$在盘前交易中，该股上涨8.8%，至9.63美元。IN8BIO最近公布第二季度每股净亏损1.00美元，而去年同期每股亏损0.92美元。
$Amryt Pharma PLC(AMYT.US)$在盘前交易中，该公司股价上涨7.7%，至11.50美元。Amryt将2021年全年收入指引提高到2.2亿至2.25亿美元。
$Ur-Energy Inc.(URG.US)$在周一攀升逾7%后，该股在盘前交易中上涨6.7%，至1.90美元。
$EyeGate制药公司(EYEG.US)$在盘前交易中上涨6%，至1.78美元。EyeGate制药公司最近完成了第二阶段概念验证研究的目标登记，以评估PP-001用于治疗眼表炎症的效果。
$Matinas BioPharma Holdings Inc.(MTNB.US)$在盘前交易中，该股上涨5.7%，至1.11美元。Matinas BioPharma股价周一上涨27%，此前该公司宣布了正在进行的MAT2203治疗隐球菌性脑膜炎的ACT试验数据。
$MarkForge Holding Corp(MKFG.US)$股价在周一下跌5%后，在盘前交易中上涨5.5%，至8.06美元。
Losers
失败者
$TMC THE METALS CO INC(TMC.US)$ shares fell 10.8% to $11.10 in pre-market trading after jumping 32% on Monday.
$Renalytix AI PLC(RNLX.US)$ shares fell 7.4% to $21.35 in pre-market trading.
$Old Republic International Corp(ORI.US)$ shares fell 5.5% to $23.73 in pre-market trading.
$Support.com(SPRT.US)$ shares fell 5% to $18.16 in pre-market trading after dropping 9% on Monday. The stock has been circulated as a potential short squeeze candidate on social media.
$Aluminum Corporation Of China(ACH.US)$ fell 5% to $22.09 in pre-market trading after gaining over 8% on Monday.
$TMC The Metals Co Inc.(TMC.US)$股价在周一大涨32%后，在盘前交易中下跌10.8%，至11.10美元。
$Renalytix AI PLC(RNLX.US)$在盘前交易中，该公司股价下跌7.4%，至21.35美元。
$旧共和国国际公司(ORI.US)$在盘前交易中，该公司股价下跌5.5%，至23.73美元。
$Support.com(SPRT.US)$股价在周一下跌9%后，在盘前交易中下跌5%，至18.16美元。该股在社交媒体上被认为是潜在的做空候选者。
$中国铝业(ACH.US)$在周一上涨超过8%的盘前交易中，该公司股价下跌5%，至22.09美元。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧